MoonLake Immunotherapeutics (MLTX) Proxy Filing summary

Executive summary

• Annual General Meeting scheduled for June 5, 2025, at 8:00 a.m. ET in New York.

• Shareholders are encouraged to review proxy materials and vote by June 4, 2025.

• Proxy materials are available online, with options for paper or email copies upon request.

Voting matters and shareholder proposals

• Election of three Class III director nominees to serve until the 2028 Annual General Meeting.

• Ratification of Baker Tilly US, LLP as independent registered public accounting firm for 2025.

• Advisory vote on the compensation of named executive officers.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Director nominees: Dr. Jorge Santos da Silva, Simon Sturge, and Dr. Andrew Phillips.